Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
- NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
- NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_assertion evidence source_evidence_literature NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
- NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_assertion SIO_000772 10368524 NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
- NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_assertion wasDerivedFrom befree-2016 NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
- NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_assertion wasGeneratedBy ECO_0000203 NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
- befree-2016 importedOn "2016-02-19" NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.